---
title: Newsroom | Healthcare
description: Healthcare |
---

[![Life Science Newswire 2](https://news.lifesciencenewswire.com/hs-fs/hubfs/Life%20Science%20Newswire%202.png?width=203&height=60&name=Life%20Science%20Newswire%202.png "Life Science Newswire 2")](https://lifesciencenewswire.com/)

- [Newsroom](https://news.lifesciencenewswire.com/newsroom)
- [Back to the main site](https://lifesciencenewswire.com/)

![LSNewswire-main-header-banner-v2-1](https://news.lifesciencenewswire.com/hubfs/LSNewswire-main-header-banner-v2-1.jpg "LSNewswire-main-header-banner-v2-1")

# Newsroom

#### Categories ![Arrow](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/sidebar.svg "Arrow")

#### Subscribe![](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/subscribe-rss-button.svg)

![](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/close-button.svg)

### Choose a Category

- [Agriculture (1)](https://news.lifesciencenewswire.com/newsroom/tag/agriculture)
- [AI (2)](https://news.lifesciencenewswire.com/newsroom/tag/ai)
- [Analytical Chemistry (42)](https://news.lifesciencenewswire.com/newsroom/tag/analytical-chemistry)
- [Biomanufacturing (35)](https://news.lifesciencenewswire.com/newsroom/tag/biomanufacturing)
- [biopharma (22)](https://news.lifesciencenewswire.com/newsroom/tag/biopharma)
- [Bioprocessing (16)](https://news.lifesciencenewswire.com/newsroom/tag/bioprocessing)
- [Biotechnology (251)](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology)
- [Cell Culture (10)](https://news.lifesciencenewswire.com/newsroom/tag/cell-culture)
- [Clinical Diagnostics (36)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-diagnostics)
- [clinical research (6)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research)
- [Clinical Research & Trials (116)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials)
- [Computing & Technology (62)](https://news.lifesciencenewswire.com/newsroom/tag/computing-it)
- [Corporate, Finance & Investor (288)](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor)
- [COVID-19 (86)](https://news.lifesciencenewswire.com/newsroom/tag/covid-19)
- [Diagnostics & Hospital Laboratory (36)](https://news.lifesciencenewswire.com/newsroom/tag/diagnostics-hospital-laboratory)
- [Digital Pathology (2)](https://news.lifesciencenewswire.com/newsroom/tag/digital-pathology)
- [Drug Discovery & Development (152)](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development)
- [Energy & Environment (15)](https://news.lifesciencenewswire.com/newsroom/tag/energy-environment)
- [excipients (1)](https://news.lifesciencenewswire.com/newsroom/tag/excipients)
- [Food & Beverage (8)](https://news.lifesciencenewswire.com/newsroom/tag/food-beverage)
- [General Chemistry (7)](https://news.lifesciencenewswire.com/newsroom/tag/general-chemistry)
- [General Laboratory (58)](https://news.lifesciencenewswire.com/newsroom/tag/general-laboratory)
- [General Science (5)](https://news.lifesciencenewswire.com/newsroom/tag/general-science)
- [Healthcare (136)](https://news.lifesciencenewswire.com/newsroom/tag/healthcare)
- [Hospital Management (7)](https://news.lifesciencenewswire.com/newsroom/tag/hospital-management)
- [Life Science (26)](https://news.lifesciencenewswire.com/newsroom/tag/life-science)
- [Manufacturing (2)](https://news.lifesciencenewswire.com/newsroom/tag/manufacturing)
- [Materials Science (2)](https://news.lifesciencenewswire.com/newsroom/tag/materials-science)
- [Medical Devices & Technology (26)](https://news.lifesciencenewswire.com/newsroom/tag/medical-devices-technology)
- [Microbiology & Infection Control (18)](https://news.lifesciencenewswire.com/newsroom/tag/microbiology-infection-control)
- [Microscopy & Imaging (47)](https://news.lifesciencenewswire.com/newsroom/tag/microscopy-imaging)
- [Nanotech (2)](https://news.lifesciencenewswire.com/newsroom/tag/nanotech)
- [Omics & Genetics (87)](https://news.lifesciencenewswire.com/newsroom/tag/omics-genetics)
- [Pathology (5)](https://news.lifesciencenewswire.com/newsroom/tag/pathology)
- [Pharma (118)](https://news.lifesciencenewswire.com/newsroom/tag/pharma)
- [Pharmacy (5)](https://news.lifesciencenewswire.com/newsroom/tag/pharmacy)
- [Research (47)](https://news.lifesciencenewswire.com/newsroom/tag/research)
- [Veterinary (6)](https://news.lifesciencenewswire.com/newsroom/tag/veterinary)
- [Water (8)](https://news.lifesciencenewswire.com/newsroom/tag/water)

See all

### Subscribe to Email Updates

<https://news.lifesciencenewswire.com/newsroom/ceryx-medical-appoints-professor-zaheer-yousef-obe-as-chief-medical-officer>

 Categories: [Healthcare](https://news.lifesciencenewswire.com/newsroom/tag/healthcare), [Clinical Research & Trials](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor)

#### [Ceryx Medical appoints Professor Zaheer Yousef OBE as Chief Medical Officer](https://news.lifesciencenewswire.com/newsroom/ceryx-medical-appoints-professor-zaheer-yousef-obe-as-chief-medical-officer)

 September 21, 2026

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/ceryx-medical-appoints-professor-zaheer-yousef-obe-as-chief-medical-officer)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/ceryx-medical-appoints-professor-zaheer-yousef-obe-as-chief-medical-officer#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Sep 21, 2026, 12:00:00 PM

- [Tweet](https://twitter.com/share)

 Categories: [Healthcare](https://news.lifesciencenewswire.com/newsroom/tag/healthcare), [Clinical Research & Trials](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials), [Veterinary](https://news.lifesciencenewswire.com/newsroom/tag/veterinary), [Hospital Management](https://news.lifesciencenewswire.com/newsroom/tag/hospital-management)

#### [Sakura Finetek Europe launches Sakura Pathology Network](https://news.lifesciencenewswire.com/newsroom/sakura-finetek-europe-launches-sakura-pathology-network)

A new initiative to connect and empower early-career pathologists across Europe

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/sakura-finetek-europe-launches-sakura-pathology-network)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/sakura-finetek-europe-launches-sakura-pathology-network#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Sep 10, 2026, 8:30:00 AM

- [Tweet](https://twitter.com/share)

<https://news.lifesciencenewswire.com/newsroom/sciensus-to-deliver-a-fully-integrated-home-pathway-for-tumour-treating-fields-ttfields-therapy>

 Categories: [Pharmacy](https://news.lifesciencenewswire.com/newsroom/tag/pharmacy), [Healthcare](https://news.lifesciencenewswire.com/newsroom/tag/healthcare), [Medical Devices & Technology](https://news.lifesciencenewswire.com/newsroom/tag/medical-devices-technology)

#### [Sciensus to deliver a fully integrated home pathway for Tumour Treating Fields (TTFields) therapy](https://news.lifesciencenewswire.com/newsroom/sciensus-to-deliver-a-fully-integrated-home-pathway-for-tumour-treating-fields-ttfields-therapy)

 August 11, 2026

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/sciensus-to-deliver-a-fully-integrated-home-pathway-for-tumour-treating-fields-ttfields-therapy)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/sciensus-to-deliver-a-fully-integrated-home-pathway-for-tumour-treating-fields-ttfields-therapy#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Aug 11, 2026, 2:00:04 PM

- [Tweet](https://twitter.com/share)

<https://news.lifesciencenewswire.com/newsroom/trajan-expands-us-availability-of-harpera-microbiopsy-punch-for-clinical-skin-sampling>

 Categories: [Healthcare](https://news.lifesciencenewswire.com/newsroom/tag/healthcare), [Clinical Research & Trials](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials)

#### [Trajan expands US availability of Harpera™ Microbiopsy Punch for clinical skin sampling](https://news.lifesciencenewswire.com/newsroom/trajan-expands-us-availability-of-harpera-microbiopsy-punch-for-clinical-skin-sampling)

 July 20, 2026

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/trajan-expands-us-availability-of-harpera-microbiopsy-punch-for-clinical-skin-sampling)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/trajan-expands-us-availability-of-harpera-microbiopsy-punch-for-clinical-skin-sampling#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Jul 20, 2026, 1:29:59 PM

- [Tweet](https://twitter.com/share)

<https://news.lifesciencenewswire.com/newsroom/ceryx-medical-ceryx-appoints-leading-medtech-executive-mark-strong-as-non-executive-director>

 Categories: [Healthcare](https://news.lifesciencenewswire.com/newsroom/tag/healthcare), [Medical Devices & Technology](https://news.lifesciencenewswire.com/newsroom/tag/medical-devices-technology)

#### [Ceryx Medical (Ceryx) appoints leading MedTech executive Mark Strong as Non-Executive Director](https://news.lifesciencenewswire.com/newsroom/ceryx-medical-ceryx-appoints-leading-medtech-executive-mark-strong-as-non-executive-director)

 January 26, 2026

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/ceryx-medical-ceryx-appoints-leading-medtech-executive-mark-strong-as-non-executive-director)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/ceryx-medical-ceryx-appoints-leading-medtech-executive-mark-strong-as-non-executive-director#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Jan 26, 2026, 12:00:00 PM

- [Tweet](https://twitter.com/share)

<https://news.lifesciencenewswire.com/newsroom/groundbreaking-myalgic-encephalomyelitis-study-identifies-over-250-core-genes-shared-biology-with-long-covid-and-dozens-of-drug-repurposing-opportunities>

 Categories: [Healthcare](https://news.lifesciencenewswire.com/newsroom/tag/healthcare), [COVID-19](https://news.lifesciencenewswire.com/newsroom/tag/covid-19), [Clinical Research & Trials](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials)

#### [Groundbreaking myalgic encephalomyelitis study identifies over 250 core genes, shared biology with long COVID, and dozens of drug repurposing opportunities](https://news.lifesciencenewswire.com/newsroom/groundbreaking-myalgic-encephalomyelitis-study-identifies-over-250-core-genes-shared-biology-with-long-covid-and-dozens-of-drug-repurposing-opportunities)

 December 4, 2025

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/groundbreaking-myalgic-encephalomyelitis-study-identifies-over-250-core-genes-shared-biology-with-long-covid-and-dozens-of-drug-repurposing-opportunities)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/groundbreaking-myalgic-encephalomyelitis-study-identifies-over-250-core-genes-shared-biology-with-long-covid-and-dozens-of-drug-repurposing-opportunities#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Dec 4, 2025, 9:09:27 AM

- [Tweet](https://twitter.com/share)

<https://news.lifesciencenewswire.com/newsroom/duke-street-bio-receives-fda-fast-track-designation-for-parp1-selective-inhibitor-dsb2455-in-patients-with-hrd-brain-metastases-from-triple-negative-breast-cancer>

 Categories: [Healthcare](https://news.lifesciencenewswire.com/newsroom/tag/healthcare), [Clinical Research & Trials](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials)

#### [Duke Street Bio receives FDA Fast Track designation for PARP1-Selective Inhibitor DSB2455 in patients with HRD brain metastases from triple-negative breast cancer](https://news.lifesciencenewswire.com/newsroom/duke-street-bio-receives-fda-fast-track-designation-for-parp1-selective-inhibitor-dsb2455-in-patients-with-hrd-brain-metastases-from-triple-negative-breast-cancer)

 June 16, 2025

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/duke-street-bio-receives-fda-fast-track-designation-for-parp1-selective-inhibitor-dsb2455-in-patients-with-hrd-brain-metastases-from-triple-negative-breast-cancer)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/duke-street-bio-receives-fda-fast-track-designation-for-parp1-selective-inhibitor-dsb2455-in-patients-with-hrd-brain-metastases-from-triple-negative-breast-cancer#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Jun 16, 2025, 12:30:00 PM

- [Tweet](https://twitter.com/share)

<https://news.lifesciencenewswire.com/newsroom/ceryx-medical-secures-15-million-to-advance-groundbreaking-heart-failure-technology>

 Categories: [Healthcare](https://news.lifesciencenewswire.com/newsroom/tag/healthcare), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor), [Medical Devices & Technology](https://news.lifesciencenewswire.com/newsroom/tag/medical-devices-technology)

#### [Ceryx Medical secures $15 million to advance groundbreaking heart failure technology](https://news.lifesciencenewswire.com/newsroom/ceryx-medical-secures-15-million-to-advance-groundbreaking-heart-failure-technology)

 June 11, 2025

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/ceryx-medical-secures-15-million-to-advance-groundbreaking-heart-failure-technology)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/ceryx-medical-secures-15-million-to-advance-groundbreaking-heart-failure-technology#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Jun 11, 2025, 10:30:00 AM

- [Tweet](https://twitter.com/share)

<https://news.lifesciencenewswire.com/newsroom/precisionlife-appoints-bill-keating-as-chief-commercial-officer-diagnostics-and-healthcare>

 Categories: [Healthcare](https://news.lifesciencenewswire.com/newsroom/tag/healthcare), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor), [Clinical Diagnostics](https://news.lifesciencenewswire.com/newsroom/tag/clinical-diagnostics)

#### [PrecisionLife appoints Bill Keating as Chief Commercial Officer, Diagnostics and Healthcare](https://news.lifesciencenewswire.com/newsroom/precisionlife-appoints-bill-keating-as-chief-commercial-officer-diagnostics-and-healthcare)

 January 8, 2025

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/precisionlife-appoints-bill-keating-as-chief-commercial-officer-diagnostics-and-healthcare)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/precisionlife-appoints-bill-keating-as-chief-commercial-officer-diagnostics-and-healthcare#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Jan 8, 2025, 2:00:00 PM

- [Tweet](https://twitter.com/share)

[All posts](https://news.lifesciencenewswire.com/newsroom/all) [Next](https://news.lifesciencenewswire.com/newsroom/tag/healthcare/page/2)

##### Browse more news

## Recent releases

<https://news.lifesciencenewswire.com/newsroom/cellcarta-establishes-strategic-partnership-with-waters-to-advance-companion-diagnostics-development>

#### [CellCarta Establishes Strategic Partnership with Waters to Advance Companion Diagnostics Development](https://news.lifesciencenewswire.com/newsroom/cellcarta-establishes-strategic-partnership-with-waters-to-advance-companion-diagnostics-development)

 October 5, 2026

Collaboration combines CellCarta’s global clinical trial testing capabilities with Waters’ standardized flow cytometry platforms and expertise CellCar...

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/cellcarta-establishes-strategic-partnership-with-waters-to-advance-companion-diagnostics-development)

<https://news.lifesciencenewswire.com/newsroom/cellcarta-and-imagene-ai-expand-collaboration-to-validate-deploy-and-scale-ai-powered-biomarker-and-companion-diagnostic-programs-across-drug-development>

#### [CellCarta and Imagene AI Expand Collaboration to Validate, Deploy and Scale AI-Powered Biomarker and...](https://news.lifesciencenewswire.com/newsroom/cellcarta-and-imagene-ai-expand-collaboration-to-validate-deploy-and-scale-ai-powered-biomarker-and-companion-diagnostic-programs-across-drug-development)

 October 1, 2026

The collaboration combines Imagene’s AI-powered assay development and biomarker prediction capabilities with CellCarta’s global companion diagnostics ...

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/cellcarta-and-imagene-ai-expand-collaboration-to-validate-deploy-and-scale-ai-powered-biomarker-and-companion-diagnostic-programs-across-drug-development)

<https://news.lifesciencenewswire.com/newsroom/ceryx-medical-appoints-professor-zaheer-yousef-obe-as-chief-medical-officer>

#### [Ceryx Medical appoints Professor Zaheer Yousef OBE as Chief Medical Officer](https://news.lifesciencenewswire.com/newsroom/ceryx-medical-appoints-professor-zaheer-yousef-obe-as-chief-medical-officer)

 September 21, 2026

Leading heart failure cardiologist and RSA-Pace principal investigator joins as the company prepares its next clinical study Ceryx Medical (Ceryx), th...

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/ceryx-medical-appoints-professor-zaheer-yousef-obe-as-chief-medical-officer)

![LS-Newswire-reverse](https://news.lifesciencenewswire.com/hs-fs/hubfs/raw_assets/public/LifeScienceNewswire_June2020/images/LS-Newswire-reverse.png?width=150&name=LS-Newswire-reverse.png "LS-Newswire-reverse")

Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225 

#### Useful information

- [Cookie and privacy policy](https://lifesciencenewswire.com/cookie-privacy-policy/)
- [Website terms and conditions](https://lifesciencenewswire.com/terms-and-conditions)
- [Promotion terms and conditions](https://lifesciencenewswire.com/promotion_terms/)